Amazon cover image
Image from Amazon.com

Emerging therapeutic targets in ovarian cancer / Stan Kaye [and others], editors.

Contributor(s): Material type: TextTextPublication details: New York : Springer Science+Business Media, LLC, ©2011.Description: 1 online resource (xiii, 291 pages) : illustrationsContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781441972163
  • 1441972161
  • 9781441972156
  • 1441972153
Subject(s): Genre/Form: Additional physical formats: Print version:: Emerging therapeutic targets in ovarian cancer.DDC classification:
  • 616.99/465 22
LOC classification:
  • RC280.O8 E44 2011
NLM classification:
  • 2011 B-194
  • WP 322
Online resources:
Contents:
Preface; Contents; Contributors; 1 Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs; 2 Discovery of Novel Targets; 3 Novel Anti-angiogenic Therapies in Ovarian Cancer; 4 Targeting the AKT Pathway in Ovarian Cancer; 5 Inhibition of the Src Oncogene: Therapeutic PotentialINTbreak; in Ovarian Carcinoma; 6 Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer; 7 Targeting Inflammatory Pathways in Epithelial Ovarian Cancer.
Summary: This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.
Tags from this library: No tags from this library for this title. Log in to add tags.
No physical items for this record

Includes bibliographical references and index.

Preface; Contents; Contributors; 1 Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs; 2 Discovery of Novel Targets; 3 Novel Anti-angiogenic Therapies in Ovarian Cancer; 4 Targeting the AKT Pathway in Ovarian Cancer; 5 Inhibition of the Src Oncogene: Therapeutic PotentialINTbreak; in Ovarian Carcinoma; 6 Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer; 7 Targeting Inflammatory Pathways in Epithelial Ovarian Cancer.

This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.

Print version record.